OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The microglial ATP‐gated ion channel P2X7 as a CNS drug target
Anindya Bhattacharya, Knut Biber
Glia (2016) Vol. 64, Iss. 10, pp. 1772-1787
Closed Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential
Kazuhide Inoue, Makoto Tsuda
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 3, pp. 138-152
Closed Access | Times Cited: 692

Purinergic Signalling: Therapeutic Developments
Geoffrey Burnstock
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 346

Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
Anne-Laure Hemonnot-Girard, Jennifer Hua, Lauriane Ulmann, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 289

Structural basis for subtype-specific inhibition of the P2X7 receptor
Akira Karasawa, Toshimitsu Kawate
eLife (2016) Vol. 5
Open Access | Times Cited: 260

The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
Geoffrey Burnstock, Gillian E. Knight
Purinergic Signalling (2017) Vol. 14, Iss. 1, pp. 1-18
Open Access | Times Cited: 205

Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 200

The P2X7 Receptor
Ronald Sluyter
Advances in experimental medicine and biology (2017), pp. 17-53
Closed Access | Times Cited: 191

Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody
Karina Kaczmarek-Hájek, Jiong Zhang, R. Kopp, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 174

Regulation of Microglial Functions by Purinergic Mechanisms in the Healthy and Diseased CNS
Péter Illés, Patrizia Rubini, Henning Ulrich, et al.
Cells (2020) Vol. 9, Iss. 5, pp. 1108-1108
Open Access | Times Cited: 170

Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration
Fangjie Shao, Xiaoyu Wang, Haijian Wu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 139

The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms
Jiao Wang, Jiayi Lin, Yanfang Deng, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 3

Depression and sterile inflammation: Essential role of danger associated molecular patterns
Tina Franklin, Chelsea Y. Xu, Ronald S. Duman
Brain Behavior and Immunity (2017) Vol. 72, pp. 2-13
Closed Access | Times Cited: 165

Neuronal P2X7 Receptors Revisited: Do They Really Exist?
Péter Illés, Tahir Muhammad Khan, Patrizia Rubini
Journal of Neuroscience (2017) Vol. 37, Iss. 30, pp. 7049-7062
Open Access | Times Cited: 154

The role of microglial P2X7: modulation of cell death and cytokine release
Yingbo He, Natalie Taylor, Lawrence Fourgeaud, et al.
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 152

Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation
Welbeck Danquah, Catherine Meyer-Schwesinger, Björn Rissiek, et al.
Science Translational Medicine (2016) Vol. 8, Iss. 366
Open Access | Times Cited: 148

P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology
Leanne Stokes, Janice A. Layhadi, Lučka Bibič, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 134

Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Deidiane Elisa Ribeiro, Ágatha Oliveira‐Giacomelli, Talita Glaser, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 4, pp. 1044-1059
Open Access | Times Cited: 126

The P2X7 Receptor: Central Hub of Brain Diseases
Roberta Andrejew, Ágatha Oliveira‐Giacomelli, Deidiane Elisa Ribeiro, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 115

Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis
Wissam Beaino, Bieneke Janssen, Gijs Kooij, et al.
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 103

PET Imaging of Microglial Activation—Beyond Targeting TSPO
Bieneke Janssen, Daniëlle J. Vugts, Albert D. Windhorst, et al.
Molecules (2018) Vol. 23, Iss. 3, pp. 607-607
Open Access | Times Cited: 103

P2X7 Receptor Signaling in Stress and Depression
Deidiane Elisa Ribeiro, Aline Lulho Roncalho, Talita Glaser, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2778-2778
Open Access | Times Cited: 103

P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
Péter Illés
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5996-5996
Open Access | Times Cited: 102

Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders
Anindya Bhattacharya
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 99

Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders
Anindya Bhattacharya, Declan N.C. Jones
Psychoneuroendocrinology (2018) Vol. 98, pp. 95-100
Closed Access | Times Cited: 88

Page 1 - Next Page

Scroll to top